用户名: 密   码:
注册 | 忘记密码?
专利详细信息
专利号
CN103301122A
专利标题 Famotidine composition for injection
专利权人 Hainan Weikang Pharmaceutical (qianshan) Co., Ltd.;
发明人
申请号 CN20131263747
申请日 2013/6/27
公开日 2013/9/18
优先权号
IPC A61K03142600;
专利类型
法律状态查询 查看法律状态


The invention provides a famotidine composition for injection and relates to the technical field of medicine manufacturing. The main medicine of the composition comprises famotidine and melatonin wherein the melatonin comprises a quick release part and a cyclodextrin-included slow release part. According to the famotidine composition for injection provided by the invention the therapeutic effect of famotidine is improved instability caused by oral administration of MT (Melatonin) is avoided and MT is quick to distribute and eliminate and the like and the first pass effect of MT is reduced. The design of dosage combining quick release and slow release is in accordance with secretion characteristic of MT so that the problem of half-life period of MT is solved and the bioavailability of melatonin is improved. Melatonin combined with famotidine can be used for effectively inhibiting the secretion of gastric acid so that the composition has a good synergistic effect for treating benign active gastric ulcer.
没有相关的数据
没有相关的数据
引证图片
暂无附图

注:除CN专利外,本系统默认提供的所有其他中文标题和摘要来自机器翻译。

上传 | 编辑 | 标注(0) | 下载专利全文 | 收藏